The World Health Organization has approved a version of a widely used cholera vaccine that could help address a surge in cases that has depleted the global vaccine stockpile and left poorer countries scrambling to contain epidemics.
WHO authorized the vaccine, made by EuBiologics, which also makes the formulation now used, last week. The new version, called Euvichol-S, is a simplified formula that uses fewer ingredients, is cheaper, and can be made more quickly than the old version.
The vaccine was shown to be help preventing the diarrheal disease in late stage research conducted in Nepal.
WHO’s approval means donor agencies like the vaccines alliance Gavi and UNICEF can now buy it for poorer countries. Leila Pakkala, director of UNICEF’s supply division, said in a statement that the agency will be able to boost supplies by more than 25%.
Mariska Hargitay is mistaken for real
Big Chinese companies brighten 2024 CES
Xi's Reply Letter : A Testament to Five Generations of Friendship
Arkansas Supreme Court says new DNA testing can be sought in 'West Memphis 3' case
China to streamline national medical insurance reimbursement system
HK's tourism continues rebound in 2023 with 34m visitors
Xi Focus: Xi Stresses Striving for Full Revitalization of Northeast China
Closing arguments set in trial of an Arizona rancher charged in fatal shooting of unarmed migrant
Xi Extends Condolences to Moroccan King over Deadly Earthquake
Husband of former Scottish leader Nicola Sturgeon is arrested again in party finance probe
Xi Calls for Better Integration of Modernization Process in China, Singapore